Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis

European Surgical Research

Volumn 39, Issue 4, 2007, Pages 229-238

  Hu, W G ^a,b   Li, J W ^a,b   Feng, B ^a,b   Beveridge, M ^c   Yue, F ^a,b   Lu, A G ^a,b   Ma, J J ^a,b   Wang, M L ^a,b   Guo, Y ^b   Jin, X L ^b   Zheng, M H ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiogenesis; Colorectal neoplasm; Lymphangiogenesis; Microvessel density; Prognosis, colorectal cancer; Vascular endothelial factor C; Vascular endothelial factor D

Indexed keywords

TUMOR MARKER; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DISEASE FREE SURVIVAL; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MICROCIRCULATION; MICROSCOPY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 34347270174     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101855     Document Type: Article

References (33)

1. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Feng B, Zheng MH, Zheng YF, et al: The normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. J Gastroenterol Hepatol 2005;20:1913-1919.
3. Feng B, Zheng MH, Ma JJ, et al: Clinical significance of human kallikrein gene 10 expression in colorectal cancer and gastric cancer. J Gastroenterol Hepatol 2006;21:1596-1603.
4. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.
5. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-458.
6. Stacker SA, Achen MG, Jussila L, et al: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-583.
7. Stacker SA, Baldwin ME, Achen MG: The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002;16:922-934.
8. Beahrs OH, Myers MH: Purposes and principles of staging; in: Manual for Staging of Cancer. Philadelphia, Lippincott, 1983, pp 3-5.
9. Tomisaki S, Ohno S, Ichiyoshi Y, et al: Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996;77(suppl 8):1722-1728.
10. Karpanen T, Egeblad M, Karkkainen MJ, et al: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001;61:1786-1790.
11. Mandriota SJ, Jussila L, Jeltsch M, et al: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672-682.
12. Skobe M, Hawighorst T, Jackson DG, et al: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-198.
13. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
14. Maier CM, Hsieh L, Yu F, et al: Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia. Stroke 2004;35:1169-1174.
15. Witkiewicz AK, Varambally S, Shen R, et al: Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1418-1423.
16. White JD, Hewett PW, Kosuge D, et al: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002;62:1669-1675.
17. Stacker SA, Achen MG: The vascular endothelial growth factor family: signaling for vascular development. Growth Factors 1999;17:1-11.
18. Joukov V, Pajusola K, Kaipainen A, et al: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298.
19. Achen MG, Jeltsch M, Kukk E, et al: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc Natl Acad Sci USA 1998;95:548-553.
20. Kaipainen A, Korhonen J, Mustonen T, et al: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-3570.
21. Veikkola T, Jussila L, Makinen T, et al: Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001;20:1223-1231.
22. Jeltsch M, Kaipainen A, Joukov V, et al: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-1425.
23. Oh S, Jeltsch M, Birkenhager R, et al: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997;188:96-109.
24. Karkkainen MJ, Haiko P, Sainio K, et al: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
25. Skobe M, Hamberg LM, Hawighorst T, et al: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001;159:893-903.
26. Kitadai Y, Kodama M, Cho S, et al: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 2005;115:388-392.
27. Endreseth BH, Romundstad P, Myrvold HE, et al: Rectal cancer in the young patient. Dis Colon Rectum 2006;49:993-1001.
28. Lin JT, Wang WS, Yen CC, et al: Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 2005;20:900-905.
29. Vermeulen PB, Van den Eynden GG, Huget P, et al: Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 1999;79:316-322.
30. Banner BF, Whitehouse R, Baker SP, et al: Tumor angiogenesis in stage II colorectal carcinoma: association with survival. Am J Clin Pathol 1998;109:733-737.
31. Lindmark G, Gerdin B, Sunberg C, et al: Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996;14:461-466.
32. Onogawa S, Kitadai Y, Tanaka S, et al: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 2004;95:32-39.
33. White JD, Hewett PW, Kosuge D, et al: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002;62:1669-1675.